237 related articles for article (PubMed ID: 34099355)
41. Primary tumor location and the prognosis of patients after local treatment of colorectal liver metastases: a systematic review and meta-analysis.
Buisman FE; Galjart B; Buettner S; Groot Koerkamp B; Grünhagen DJ; Verhoef C
HPB (Oxford); 2020 Mar; 22(3):351-357. PubMed ID: 31668753
[TBL] [Abstract][Full Text] [Related]
42. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
[TBL] [Abstract][Full Text] [Related]
43. The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
Margonis GA; Buettner S; Andreatos N; Wagner D; Sasaki K; Galjart B; Kamphues C; Pawlik TM; Poultsides G; Kaczirek K; Lønning PE; Verhoef C; Kreis ME; Wolfgang CL; Weiss MJ
J Surg Oncol; 2018 Dec; 118(7):1074-1080. PubMed ID: 30261094
[TBL] [Abstract][Full Text] [Related]
44. KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases.
Kemeny NE; Chou JF; Capanu M; Gewirtz AN; Cercek A; Kingham TP; Jarnagin WR; Fong YC; DeMatteo RP; Allen PJ; Shia J; Ang C; Vakiani E; D'Angelica MI
Cancer; 2014 Dec; 120(24):3965-71. PubMed ID: 25155157
[TBL] [Abstract][Full Text] [Related]
45. Recurrence patterns after laparoscopic resection of colorectal liver metastases.
Tabchouri N; Gayet B; Okumura S; Donatelli G; Beaussier M; Bennamoun M; Louvet C; Fuks D
Surg Endosc; 2018 Dec; 32(12):4788-4797. PubMed ID: 29761279
[TBL] [Abstract][Full Text] [Related]
46. Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE).
Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; de Vries JJJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Meijerink MR
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440165
[TBL] [Abstract][Full Text] [Related]
47. Impact of Metformin Use on Survival in Patients Undergoing Liver Resection for Colorectal Cancer Metastases.
Kaltenmeier C; Morocco B; Yazdani H; Reitz K; Meyer K; Molinari M; Geller D; Tohme S
Am Surg; 2021 Nov; 87(11):1766-1774. PubMed ID: 34766506
[TBL] [Abstract][Full Text] [Related]
48. Anatomic Resection Is Not Required for Colorectal Liver Metastases with RAS Mutation.
Joechle K; Vreeland TJ; Vega EA; Okuno M; Newhook TE; Panettieri E; Chun YS; Tzeng CD; Aloia TA; Lee JE; Vauthey JN
J Gastrointest Surg; 2020 May; 24(5):1033-1039. PubMed ID: 32162236
[TBL] [Abstract][Full Text] [Related]
49. Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.
Margonis GA; Buettner S; Andreatos N; Sasaki K; Ijzermans JNM; van Vugt JLA; Pawlik TM; Choti MA; Cameron JL; He J; Wolfgang CL; Weiss MJ
Ann Surg; 2017 Oct; 266(4):641-649. PubMed ID: 28657938
[TBL] [Abstract][Full Text] [Related]
50. Surgical and oncologic outcomes following repeat hepatic resection of colorectal liver metastasis: Who benefits?
Wong LH; Sutton TL; Walker BS; Lopez CD; Kardosh A; Eil RL; Chen EY; Billingsley KG; Mayo SC
Am J Surg; 2021 Jun; 221(6):1114-1118. PubMed ID: 33722380
[TBL] [Abstract][Full Text] [Related]
51. Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study.
Wang X; Wei Q; Gao J; Li J; Li J; Gong J; Li Y; Shen L
Chin J Cancer; 2017 Oct; 36(1):81. PubMed ID: 29037218
[TBL] [Abstract][Full Text] [Related]
52. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.
Passot G; Chun YS; Kopetz SE; Overman MJ; Conrad C; Aloia TA; Vauthey JN
Eur J Surg Oncol; 2016 Sep; 42(9):1378-84. PubMed ID: 27358198
[TBL] [Abstract][Full Text] [Related]
53. The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.
Creasy JM; Sadot E; Koerkamp BG; Chou JF; Gonen M; Kemeny NE; Saltz LB; Balachandran VP; Peter Kingham T; DeMatteo RP; Allen PJ; Jarnagin WR; D'Angelica MI
Ann Surg Oncol; 2018 Feb; 25(2):431-438. PubMed ID: 29181680
[TBL] [Abstract][Full Text] [Related]
54. Impact of primary cancer features on behaviour of colorectal liver metastases and survival after hepatectomy.
Cucchetti A; Russolillo N; Johnson P; Tarchi P; Ferrero A; Cucchi M; Serenari M; Ravaioli M; de Manzini N; Cescon M; Ercolani G
BJS Open; 2019 Apr; 3(2):186-194. PubMed ID: 30957066
[TBL] [Abstract][Full Text] [Related]
55. BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy.
Teng HW; Huang YC; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Wang HW; Chang SC; Lan YT; Lin CC; Wang HS; Yang SH
J Surg Oncol; 2012 Aug; 106(2):123-9. PubMed ID: 22331825
[TBL] [Abstract][Full Text] [Related]
56. Chemotherapy for patients with colorectal liver metastases who underwent curative resection improves long-term outcomes: systematic review and meta-analysis.
Araujo RL; Gönen M; Herman P
Ann Surg Oncol; 2015 Sep; 22(9):3070-8. PubMed ID: 25586244
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients.
Hashimoto M; Kobayashi T; Ishiyama K; Ide K; Ohira M; Tahara H; Kuroda S; Hamaoka M; Iwako H; Okimoto M; Ohdan H
Int J Surg; 2016 Dec; 36(Pt A):96-103. PubMed ID: 27741421
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value of the combination of primary tumor location and RAS mutational status on patients with colorectal liver metastasis undergoing hepatectomy.
Yan XL; Wang K; Bao Q; Wang HW; Jin KM; Su YM; Xing BC
J Surg Oncol; 2022 May; 125(6):1002-1012. PubMed ID: 35171534
[TBL] [Abstract][Full Text] [Related]
59. Prognostic impact of conversion hepatectomy for initially unresectable colorectal liver metastasis.
Takamizawa Y; Inoue M; Moritani K; Tsukamoto S; Esaki M; Shimada K; Kanemitsu Y
Langenbecks Arch Surg; 2022 Nov; 407(7):2893-2903. PubMed ID: 36068379
[TBL] [Abstract][Full Text] [Related]
60. Impact of surgical margins on overall and recurrence-free survival in parenchymal-sparing laparoscopic liver resections of colorectal metastases.
Montalti R; Tomassini F; Laurent S; Smeets P; De Man M; Geboes K; Libbrecht LJ; Troisi RI
Surg Endosc; 2015 Sep; 29(9):2736-47. PubMed ID: 25427420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
